Search results for "Mycose"

showing 10 items of 351 documents

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

2006

Background: Micafungin (FK463) is a new lipopeptide compound (echinocandin) with activity against Aspergillus and Candida species. This study evaluated the safety and efficacy of micafungin in patients with proven or probable invasive aspergillosis (IA). Methods: A multinational, non-comparative study was conducted to examine proven or probable (pulmonary only) Aspergillus species infection in a wide variety of patient populations. The study employed an open-label design utilizing micafungin alone or in combination with another systemic antifungal agent. Criteria for IA and therapeutic responses were judged by an independent panel. Results: Of the 331 patients enrolled, only 225 met diagnos…

MaleAntifungal Agentsmedicine.medical_treatmentSalvage therapyHematopoietic stem cell transplantationAspergillosisGastroenterologyEchinocandinsAmphotericin BChildAged 80 and overResearch Support Non-U.S. Gov'tMiddle AgedLipoproteins [administration & dosage]Infectious DiseasesChild PreschoolAcute DiseaseCombinationDrug Therapy CombinationFemalemedicine.drugAdultMicrobiology (medical)medicine.medical_specialtyAdolescentEchinocandinLipoproteinsBiologyAntifungalPeptides CyclicArticleLipopeptidesPharmacotherapyInternal medicineAmphotericin BmedicineHumansAspergillosisEchinocandinAgedChemotherapyAspergillosis [drug therapy]MicafunginInfantmedicine.diseasebacterial infections and mycosesSurgeryPeptides Cyclic [administration & dosage]MicafunginAntifungal Agents [administration & dosage]
researchProduct

The Effect of Age, Gender, and Insertion Site on Marginal Bone Loss around Endosseous Implants: Results from a 3-Year Trial with Premium Implant Syst…

2014

Objectives.The goal of this study was to evaluate bone changes around endosseous implants in partially edentulous patients.Materials and Methods.A total of 632 two-stage implants were placed in 252 patients. The implants had straight emergence profile, ZirTi surface, 3.3 to 5 mm diameter, and 8.5 to 13 mm length. Bone levels were assessed on orthopantomography immediately after surgery and after 36 months and marginal bone loss (MBL) was calculated from their difference.Results.Cumulative survival rate was 98.73%. Overall MBL was 0.8 mm ± 0.03 (mean ± SEM). Higher MBL was observed around implants in the maxilla than in the mandible (P<0.007). A relation between implant diameter and MBL (…

MaleArticle SubjectRadiographyAlveolar Bone Losslcsh:MedicineDentistryInsertion sitechemical and pharmacologic phenomenaComorbidityGeneral Biochemistry Genetics and Molecular BiologyAge DistributionDental Implants Single-ToothPostoperative ComplicationsOlder patientsRisk FactorsMedicineDental Implantation Endosseous EndodonticHumansEndosseous implantsDental Restoration FailureSex DistributionOrthodonticsGeneral Immunology and Microbiologybusiness.industryIncidence (epidemiology)IncidenceJaw Edentulous Partiallylcsh:RMandibleGeneral MedicineDental Marginal AdaptationMiddle Agedbacterial infections and mycosesCausalityRadiographyTreatment OutcomeItalyMaxillaClinical StudyFemaleImplantbusinessBioMed Research International
researchProduct

Ligand‐Specific αβ and γδ T Cell Responses in Childhood Tuberculosis

2000

The alphabeta and gammadelta T cell responses were analyzed in the peripheral blood of children affected by active tuberculosis (TB) and in healthy children who tested positive (PPD+) or negative (PPD-) for purified protein derivative. PPD+ healthy and diseased children responded equally well to PPD in vitro. In contrast, only 18% of PPD+ TB patients responded to peptide p38G derived from the 38-kDa protein of Mycobacterium tuberculosis. Analysis of the whole gammadelta T cell population and of its Vgamma9/Vdelta2 subset showed similar frequencies in PPD+ children with TB and in healthy PPD+ and PPD- children. Vgamma9/Vdelta2 cells from children with TB responded to 5 different phosphoantig…

MaleCellular immunityTuberculosisAdolescentTuberculosiReceptors Antigen T-Cell alpha-betaLymphocyteT cellPopulationTuberculinchemical and pharmacologic phenomenacomplex mixturesMycobacterium tuberculosisFemale.Immunology and AllergyMedicineeducationeducation.field_of_studybiologybusiness.industryInfantReceptors Antigen T-Cell gamma-deltahemic and immune systemsT lymphocytebacterial infections and mycosesmedicine.diseasebiology.organism_classificationVirologyrespiratory tract diseasesInfectious Diseasesmedicine.anatomical_structureChild PreschoolImmunologybusinessHumanThe Journal of Infectious Diseases
researchProduct

Emergence of tularemia in France: paradigm of the Burgundy region

2011

International audience; We report three consecutive cases of tularemia occurring in Burgundy, France, a region previously considered not endemic for tularemia. The patients presented with varied and unspecific clinical manifestations. The epidemiological circumstances, especially the mode of contamination, were not particularly suggestive of tularemia. Serological diagnosis was delayed in two cases because of the lack of significant antibody titers at the time of admission. In contrast, a diagnosis could readily be obtained in all three cases by detection of Francisella tularensis DNA from clinical samples using PCR-based methods. These cases highlight the increased incidence and geographic…

MaleEpidemiologyMESH: Lymph NodesCommunicable Diseases EmergingSerologyTularemia0302 clinical medicineMESH: Early DiagnosisEpidemiologyDiagnosisMESH: Communicable Diseases Emerging030212 general & internal medicineMESH: DoxycyclineFrancisella tularensisTularemia0303 health sciencesMESH: TularemiaMESH: Middle AgedbiologyMESH: Real-Time Polymerase Chain ReactionIncidence (epidemiology)[SDV.BID.EVO]Life Sciences [q-bio]/Biodiversity/Populations and Evolution [q-bio.PE]Antibody titerGeneral Medicinerespiratory systemMiddle Aged3. Good healthAnti-Bacterial AgentsInfectious DiseasesFrancisella tularensis DNADoxycyclineFemaleFranceFluoroquinolonesAdultDNA BacterialMicrobiology (medical)medicine.medical_specialtyReal-Time Polymerase Chain Reactioncomplex mixtures03 medical and health sciencesMESH: Francisella tularensisMESH: Anti-Bacterial AgentsmedicineHumansFrancisella tularensisMESH: Humans030306 microbiologyMESH: AdultMESH: Fluoroquinolonesbiology.organism_classificationmedicine.diseasebacterial infections and mycosesVirologyMESH: DNA BacterialMESH: MaleMESH: FranceEarly DiagnosisbacteriaLymph NodesMESH: FemaleReal-time PCRInternational Journal of Infectious Diseases
researchProduct

Demonstration of spotted fever group rickettsiae in the tache noire of a healthy person in Sicily.

1984

A human case of rickettsial infection occurred in Sicily following tick bite. The patient did not have fever, the typical nodular rash, or other symptoms of illness other than development of a tache noire containing spotted fever group rickettsiae, which were demonstrated by immunofluorescence. A high titer of antibodies of the IgG class suggests that the patient may have had previous exposure to Rickettsia conorii or a related spotted fever group rickettsia. An anamnestic response may be hypothesized to have conferred partial immunity, with resulting containment of rickettsiae at the site of inoculation.

MaleFluorescent Antibody TechniqueRickettsiaceae InfectionsTickBoutonneuse FeverVirologySkin UlcermedicineHumansRickettsiaSicilybiologyTache noir de la sclerotiqueMiddle Agedbacterial infections and mycosesmedicine.diseasebiology.organism_classificationRashVirologyAntibodies BacterialSpotted feverBoutonneuse feverTiterInfectious DiseasesRickettsiaImmunologybacteriaParasitologymedicine.symptomRickettsia conoriiThe American journal of tropical medicine and hygiene
researchProduct

The HLA system and leprosy in Thailand

1978

To investigate immunogenetics of leprosy, 205 leprosy patients (26 with tuberculoid, 57 with borderline-tuberculoid, 21 with borderline, 31 with borderline-lepromatous, and 70 with lepromatous leprosy) have been typed for HLA antigens, and compared with 183 healthy controls from the same region (Northern Thailand). There was no significant difference between the overall group of leprosy patients or the three borderline classes and the controls. The two polar forms, tuberculoid and lepromatous leprosy, however, showed significant associations: HLA-A2 is decreased and HLA-Bw17 is increased in tuberculoid leprosy; HLA-B7 is increased in lepromatous leprosy. When both polar forms are compared w…

MaleLepromatous leprosyRacial GroupsSignificant differenceTuberculoid leprosyImmunogeneticsHuman leukocyte antigenBiologyThailandbacterial infections and mycosesmedicine.diseaseSex FactorsGene FrequencyGenesHLA AntigensLeprosyImmunologyGeneticsmedicineHumansFemaleIn patientLeprosyGenetics (clinical)Human Genetics
researchProduct

Differential expression of the murine mannose-binding lectins A and C in lymphoid and nonlymphoid organs and tissues.

2003

Abstract Mannose-binding lectin (MBL), a member of the collectin family, binds to carbohydrate structures on the surfaces of micro-organisms and may serve as a recognition molecule of the lectin pathway of complement activation. In rodents two forms, MBL-A and MBL-C, were described and shown to be products of two related, but uncoupled, genes. The liver is the main source of MBL biosynthesis. For rat MBL-A, expression has also been described in the kidney. Here we report that the two forms of murine MBL are differentially expressed in a number of nonhepatic tissues. Real-time RT-PCR revealed that the liver is the major site of expression for both MBL genes. Lower copy numbers were found in …

MaleLymphoid TissueImmunologyCollectinchemical and pharmacologic phenomenaIn situ hybridizationMannose-Binding LectinMiceIntestine SmallImmunology and AllergyAnimalsProtein IsoformsIn Situ HybridizationMannan-binding lectinMice Inbred BALB CInnate immune systembiologyLectinbacterial infections and mycosesAcquired immune systemMolecular biologyImmunohistochemistryComplement systemAnimals NewbornLiverOrgan SpecificityLectin pathwaybiology.proteinFemaleSpleenJournal of immunology (Baltimore, Md. : 1950)
researchProduct

tst1-positive ST22-MRSA-IVa in healthy Italian preschool children

2013

A survey was performed in May 2013 to assess methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in healthy children attending 26 municipal daycare centres in Palermo, Italy. Of the 500 children, ten (2 %) tested positive. Eight MRSA isolates were tst1-positive ST22-MRSA-IVa, spa t223; the other two isolates were identified as ST1-IVa and ST398-V, respectively. tst1-positive ST22-MRSA, spa t223 has been previously identified only in the Middle Eastern area.

MaleMethicillin-Resistant Staphylococcus aureusMicrobiology (medical)Pediatricsmedicine.medical_specialtySettore MED/07 - Microbiologia E Microbiologia ClinicaGenotypeMEDLINEmedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataMolecular typingSettore MED/38 - Pediatria Generale E SpecialisticaGenotypemedicineHumansHealthy childrenNasal colonizationSicilyMolecular EpidemiologyMolecular epidemiologyMiddle Eastern areabusiness.industryData CollectionGeneral MedicineStaphylococcal Infectionsbiochemical phenomena metabolism and nutritionbacterial infections and mycosesST22-MRSA-IVaMolecular TypingInfectious DiseasesStaphylococcus aureusChild PreschoolCarrier StateDaycare centerFemalebusiness
researchProduct

Colonization of pressure ulcers by multidrug-resistant microorganisms in patients receiving home care

2011

Colonization and/or infection with multidrug-resistant microorganisms (MDRO) of pressure ulcers in patients receiving care at home have seldom been investigated. The objective of this study was to assess the prevalence of MDRO colonization in pressure ulcers of patients receiving home care in Palermo, Italy. Vancomycin-resistant Enterococcus (VRE), methicillinresistant Staphylococcus aureus (MRSA), and multidrug-resistant Gram-negative bacilli (MDRGN) were isolated, identifi ed, and characterized from pressure ulcers and selected home environment surfaces. Thirty-two patients were enrolled, of whom 12 were under antimicrobial therapy. Five patients had been admitted to hospital in the prece…

MaleMethicillin-Resistant Staphylococcus aureusMicrobiology (medical)medicine.medical_specialtymultidrug-resistantDrug resistancemedicine.disease_causeDrug Resistance Multiple BacterialInternal medicineGram-Negative BacteriaEpidemiologyHumansMedicineIn patientColonizationIntensive care medicineAgedAged 80 and overPressure UlcerGeneral Immunology and Microbiologybiologybusiness.industrySkin Diseases BacterialGeneral MedicineMiddle Agedbiochemical phenomena metabolism and nutritionbacterial infections and mycosesbiology.organism_classificationAntimicrobialHome Care ServicesAnti-Bacterial AgentsMultiple drug resistanceInfectious DiseasesItalyEnterococcusStaphylococcus aureusFemalehome carebusinessEnterococcusScandinavian Journal of Infectious Diseases
researchProduct

Methicillin-resistant Staphylococcus aureus colonization: a three-year prospective study in a neonatal intensive care unit in Italy.

2014

Background: Methicillin resistant Staphylococcus aureus (MRSA) is a major etiological agent of infection in neonatal intensive care units (NICUs). Routes of entry of this organism can be different and the transmission pathway complex. Colonized neonates are the main endogenous reservoir. Methods and Results: We conducted a prospective three-year study on MRSA colonization recruiting 722 neonates admitted between 2009 and 2012. Nasal swabs were cultured weekly and MRSA isolates were submitted to molecular typing. The annual incidence density of acquisition of MRSA ranged from a maximum of 20.2 cases for 1000 patient-days during the first year to a minimum of 8.8 cases in the second one to ra…

MaleMethicillin-Resistant Staphylococcus aureusSettore MED/07 - Microbiologia E Microbiologia ClinicaPediatricsmedicine.medical_specialtyMeticillinNeonatal intensive care unitInfectious Disease ControlClinical Research DesignEpidemiologyBacterial diseasesPrevalenceColony Count Microbiallcsh:MedicineDrug resistanceSettore MED/42 - Igiene Generale E Applicatamedicine.disease_causePediatricsInfectious Disease EpidemiologySettore MED/01 - Statistica MedicaSettore MED/38 - Pediatria Generale E SpecialisticaIntensive careIntensive Care Units NeonatalNosocomial infectionsmedicineHumansColonizationProspective Studieslcsh:ScienceMolecular EpidemiologyMultidisciplinarybusiness.industrylcsh:RInfant NewbornOutbreakStaphylococcal Infectionsbacterial infections and mycosesMethicillin-resistant Staphylococcus aureusMolecular TypingMethicillin resistant Staphylococcus aureus neonatal intensive care unitMedicineInfectious diseasesFemalelcsh:QNeonatologybusinessmedicine.drugResearch ArticlePLoS ONE
researchProduct